
The Cigna Corp
Cigna Corporation (CI) is a large, USβbased healthβcare and services company combining traditional health insurance with pharmacy and careβmanagement services through its Evernorth business. Its revenue mix includes employer and individual medical plans, Medicare products, and pharmacy benefit management and care solutions. Investors typically watch member trends, medical cost inflation, price negotiations with providers and drugβpricing dynamics β all of which can move margins and earnings. Cignaβs business is sensitive to regulation, reimbursement changes and economic cycles that affect employer-sponsored coverage. With a market capitalisation of about $82.08 billion, itβs considered a major industry participant, but not immune to competition from insurers, PBMs and new entrants. This summary is general educational information, not personalised financial advice. Investors should consider their own circumstances, risk tolerance and seek regulated advice if needed; values can fall as well as rise and past performance is not a guide to future results.
Why It's Moving

Cigna Upgraded by Bernstein as Analyst Consensus Strengthens on Growth Outlook
- Bernstein upgraded Cigna from Market Perform to Outperform on March 12, raising its price target from $307 to $358, reflecting a shift in analyst sentiment toward the healthcare space
- Consensus price targets across major firms average $345-$370, implying 25-38% upside potential and suggesting analysts see significant room for the stock to appreciate
- The upgrade comes as Cigna trades below analyst target ranges, positioning the gap as an opportunity for investors monitoring the healthcare sector's recent positive momentum

Cigna Upgraded by Bernstein as Analyst Consensus Strengthens on Growth Outlook
- Bernstein upgraded Cigna from Market Perform to Outperform on March 12, raising its price target from $307 to $358, reflecting a shift in analyst sentiment toward the healthcare space
- Consensus price targets across major firms average $345-$370, implying 25-38% upside potential and suggesting analysts see significant room for the stock to appreciate
- The upgrade comes as Cigna trades below analyst target ranges, positioning the gap as an opportunity for investors monitoring the healthcare sector's recent positive momentum
When is the next earnings date for The Cigna Corp (CI)?
The Cigna Group (CI) is expected to release its next earnings on April 30, 2026 before market open, covering the Q1 2026 results. This date aligns with the company's historical pattern of reporting earnings in late April. Following this announcement, the subsequent earnings releases are projected for May 6, 2026 for Q1 2026 results, with additional reports anticipated in August and November 2026.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Cigna's stock, believing it could rise to $324.34 from $279.12.
Financial Health
Cigna is showing strong performance with good profits, cash flow, and solid revenue growth.
Dividend
Cigna's dividend yield of 2.12% offers a moderate return for income-focused investors. If you invested $1000 you would be paid $21.20 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CI
Healthcare's Cybersecurity Imperative
The massive cyberattack on UnitedHealth's subsidiary has exposed critical vulnerabilities within the national healthcare system. This event is accelerating the demand for advanced cybersecurity solutions, creating a significant growth opportunity for firms that specialize in protecting sensitive medical data and infrastructure.
Published: August 15, 2025
Explore BasketFollowing Buffett's Healthcare Bet
Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.
Published: August 15, 2025
Explore BasketHealthcare In The Crosshairs: Insurers Under Scrutiny
The Department of Justice is investigating UnitedHealth Group's Medicare billing, creating uncertainty for the nation's largest insurer. This situation presents a potential opportunity for rival health insurers to gain market share and for compliance-focused companies that help the industry navigate complex regulations.
Published: July 25, 2025
Explore BasketHealthcare Billing Integrity
This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.
Published: July 11, 2025
Explore BasketMedicaid Politics
Discover companies whose fortunes are closely tied to government healthcare funding decisions. These carefully selected stocks represent businesses with significant exposure to Medicaid, now facing heightened legislative uncertainty after Senator Tillis's retirement.
Published: June 30, 2025
Explore BasketEmployee Mental Health As A Benefit
Discover companies transforming workplace wellness through innovative mental health solutions. These carefully selected stocks represent businesses helping corporations attract and retain talent by offering digital therapy, virtual counseling, and wellness technologies as employee benefits.
Published: June 17, 2025
Explore BasketWhy Youβll Want to Watch This Stock
Pharmacy & care growth
Evernorthβs pharmacy and careβmanagement services can drive revenue diversification and margin enhancement, though execution and pricing pressure matter.
USβfocused footprint
Cignaβs operations are primarily USβcentred, so domestic regulation and employer benefits trends heavily influence results; global shocks can still have indirect effects.
Regulation and margins
Policy shifts, reimbursement rates and drug pricing reforms can materially affect profitability β investors should factor regulatory risk into valuations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Chemed Corp.
Provides hospice and palliative care services to patients facing life-limiting illness
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Companyβs operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVAβs capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
Brookdale Senior Living Inc.
A leading owner and operator of senior living communities in the United States.